The post Wall Street analysts update AMD stock price for the next 12 months appeared on BitcoinEthereumNews.com. Shares of Advanced Micro Devices (NASDAQ: AMD) have surged to an all-time high as the company continues to benefit from its role in the booming artificial intelligence (AI) sector.  Amid this momentum, Wall Street’s updated outlook projects a modest drop over the next 12 months. At the close of the last market session, AMD was trading at $252.92, up more than 7% for the day, while year-to-date, the stock has gained roughly 110%. AMD YTD stock price chart. Source: Finbold The rally follows several key developments, including a landmark multi-year agreement with OpenAI. Under the deal, AMD will supply six gigawatts of AI compute power using its MI450 GPUs, positioning the company as a key partner in AI infrastructure and challenging Nvidia’s market dominance. The agreement also includes an option for OpenAI to acquire up to 160 million AMD shares. Investor confidence has been further boosted by a partnership with Oracle Cloud to deploy 50,000 next-generation GPUs and AMD’s involvement in IBM’s recent quantum computing breakthrough using its FPGAs. Strong financial performance, including a projected Q3 revenue of $8.7 billion, has reinforced optimism.  Wall Street predicts AMD stock price  On Wall Street, the American semiconductor giant has been given a ‘Moderate Buy’ rating by 39 analysts tracked by TipRanks. The average 12-month price target stands at $249.92, representing a 1.19% downside from the stock’s last closing price. Notably, the highest forecast sits at $310 and the lowest at $160.  AMD 12-month stock price chart. Source: TipRanks Of the 39 analysts, 29 recommend a ‘Buy,’ 10 suggest a ‘Hold,’ and none have issued a ‘Sell’ rating. On October 22, Kevin Cassidy of Bernstein reiterated a ‘Market Perform’ rating on AMD with a $200 price target. Cassidy noted that while AMD’s strategic move with OpenAI, giving up 10% equity to secure AI… The post Wall Street analysts update AMD stock price for the next 12 months appeared on BitcoinEthereumNews.com. Shares of Advanced Micro Devices (NASDAQ: AMD) have surged to an all-time high as the company continues to benefit from its role in the booming artificial intelligence (AI) sector.  Amid this momentum, Wall Street’s updated outlook projects a modest drop over the next 12 months. At the close of the last market session, AMD was trading at $252.92, up more than 7% for the day, while year-to-date, the stock has gained roughly 110%. AMD YTD stock price chart. Source: Finbold The rally follows several key developments, including a landmark multi-year agreement with OpenAI. Under the deal, AMD will supply six gigawatts of AI compute power using its MI450 GPUs, positioning the company as a key partner in AI infrastructure and challenging Nvidia’s market dominance. The agreement also includes an option for OpenAI to acquire up to 160 million AMD shares. Investor confidence has been further boosted by a partnership with Oracle Cloud to deploy 50,000 next-generation GPUs and AMD’s involvement in IBM’s recent quantum computing breakthrough using its FPGAs. Strong financial performance, including a projected Q3 revenue of $8.7 billion, has reinforced optimism.  Wall Street predicts AMD stock price  On Wall Street, the American semiconductor giant has been given a ‘Moderate Buy’ rating by 39 analysts tracked by TipRanks. The average 12-month price target stands at $249.92, representing a 1.19% downside from the stock’s last closing price. Notably, the highest forecast sits at $310 and the lowest at $160.  AMD 12-month stock price chart. Source: TipRanks Of the 39 analysts, 29 recommend a ‘Buy,’ 10 suggest a ‘Hold,’ and none have issued a ‘Sell’ rating. On October 22, Kevin Cassidy of Bernstein reiterated a ‘Market Perform’ rating on AMD with a $200 price target. Cassidy noted that while AMD’s strategic move with OpenAI, giving up 10% equity to secure AI…

Wall Street analysts update AMD stock price for the next 12 months

2025/10/27 01:34

Shares of Advanced Micro Devices (NASDAQ: AMD) have surged to an all-time high as the company continues to benefit from its role in the booming artificial intelligence (AI) sector. 

Amid this momentum, Wall Street’s updated outlook projects a modest drop over the next 12 months.

At the close of the last market session, AMD was trading at $252.92, up more than 7% for the day, while year-to-date, the stock has gained roughly 110%.

AMD YTD stock price chart. Source: Finbold

The rally follows several key developments, including a landmark multi-year agreement with OpenAI. Under the deal, AMD will supply six gigawatts of AI compute power using its MI450 GPUs, positioning the company as a key partner in AI infrastructure and challenging Nvidia’s market dominance. The agreement also includes an option for OpenAI to acquire up to 160 million AMD shares.

Investor confidence has been further boosted by a partnership with Oracle Cloud to deploy 50,000 next-generation GPUs and AMD’s involvement in IBM’s recent quantum computing breakthrough using its FPGAs. Strong financial performance, including a projected Q3 revenue of $8.7 billion, has reinforced optimism. 

Wall Street predicts AMD stock price 

On Wall Street, the American semiconductor giant has been given a ‘Moderate Buy’ rating by 39 analysts tracked by TipRanks. The average 12-month price target stands at $249.92, representing a 1.19% downside from the stock’s last closing price. Notably, the highest forecast sits at $310 and the lowest at $160. 

AMD 12-month stock price chart. Source: TipRanks

Of the 39 analysts, 29 recommend a ‘Buy,’ 10 suggest a ‘Hold,’ and none have issued a ‘Sell’ rating.

On October 22, Kevin Cassidy of Bernstein reiterated a ‘Market Perform’ rating on AMD with a $200 price target. Cassidy noted that while AMD’s strategic move with OpenAI, giving up 10% equity to secure AI market access, was surprising, it was understandable given AMD’s strong financial health. He highlighted improving PC and server markets, market share gains, and a solid near-term outlook but cautioned that the market might be overly optimistic about AMD’s ramp-up through 2027. 

Meanwhile, on October 20, Vivek Arya of BofA Securities raised AMD’s price target to $300 from $250, maintaining a ‘Buy’ rating. Arya’s upgrade followed AMD’s announcements at the 2025 OCP Conference, particularly the launch of the MI450 Series “Helios” racks expected in late 2026, underscoring AMD’s growing presence in AI infrastructure.

Earlier, on October 15, Matt Bryson of Wedbush increased AMD’s price target to $270 from $190, keeping an ‘Outperform’ rating. Bryson cited AMD’s significant AI partnerships, notably with Oracle, which plans to deploy 50,000 MI450 GPUs in its AI supercluster by Q3 2026. He also highlighted AMD’s Helios open rack-scale AI platform, designed to support next-generation AI workloads.

Featured image via Shutterstock

Source: https://finbold.com/wall-street-analysts-update-amd-stock-price-for-the-next-12-months/

Disclaimer: The articles reposted on this site are sourced from public platforms and are provided for informational purposes only. They do not necessarily reflect the views of MEXC. All rights remain with the original authors. If you believe any content infringes on third-party rights, please contact service@support.mexc.com for removal. MEXC makes no guarantees regarding the accuracy, completeness, or timeliness of the content and is not responsible for any actions taken based on the information provided. The content does not constitute financial, legal, or other professional advice, nor should it be considered a recommendation or endorsement by MEXC.
Share Insights

You May Also Like

CME Group to offer 24/7 crypto futures and options in 2026

CME Group to offer 24/7 crypto futures and options in 2026

The post CME Group to offer 24/7 crypto futures and options in 2026 appeared on BitcoinEthereumNews.com. CME Group prepares to offer 24/7 coverage for cryptocurrency options and futures, finally mimicking crypto native markets. The proposal will take force after regulatory approval.  CME Group, the leading derivatives marketplace, plans to introduce cryptocurrency futures and options with 24/7 availability in early 2026.  Starting early 2026, trade crypto on your schedule. 🚀 ➡️ https://t.co/x1FLEwVAnl pic.twitter.com/RmCGMLWh4h — CME Group (@CMEGroup) October 2, 2025 The markets will be available at the beginning of 2026, pending regulatory review. Currently, the market operates with a daily settlement, though allowing early trading at settlement prices.  The new drive for round-the-clock trading follows increased demand for crypto services, and the advantage of crypto-native exchanges is undeniable. CME may now tap other regions, offering more active trading with expectations for an ongoing bull market in 2026. CME Group to offer 24/7 access through Globex Crypto markets are usually active based on regional hours, with a spike from the Asian and European markets, followed by US markets.  ‘While not all markets lend themselves to operating 24/7, client demand for around-the-clock cryptocurrency trading has grown as market participants need to manage their risk every day of the week,’ said Tim McCourt, Global Head of Equities, FX and Alternative Products at CME Group.  Cryptocurrency is the ideal market for 24/7 trading. CME Globex will offer the service, though with a two-hour weekly maintenance period over the weekend. Trades over holidays and weekends will have a trade day on the following business day.  Unlike native markets, clearing, settlement, and reporting will be processed on the following business day.  CME Group reaches peak crypto activity in 2025 Demand for crypto futures and options peaked on CME in 2025. As of September 18, the market noted peak notional open interest at $39B. August was a record month for CME, with 335,200 contracts,…
Share
BitcoinEthereumNews2025/10/03 01:06
Ross Ulbricht sets the record straight as Kamala Harris’s critique misses the mark

Ross Ulbricht sets the record straight as Kamala Harris’s critique misses the mark

The post Ross Ulbricht sets the record straight as Kamala Harris’s critique misses the mark appeared on BitcoinEthereumNews.com. Ross Ulbricht, creator of Silk Road and one of Bitcoin’s earliest public champions, didn’t waste time calling out Kamala Harris after she labeled him “the fentanyl dealer” in her new book, also criticizing President Trump for commuting his sentence. Ulbricht set the record straight: he was never prosecuted for dealing drugs personally, and fentanyl wasn’t part of his charges. Harris’s book claim sparks pushback Ulbricht’s post pulls no punches. His message is clear: Harris’s assertion was factually inaccurate, and the motivation behind it appears political, painting both Ulbricht and President Trump in a negative light. Ulbricht wrote: “The truth has never mattered to you. The goal is just to make me and President Trump look bad at all cost, isn’t it? Don’t be a sore loser, Kamala.” Democrats have long been accused of hostile attitudes toward the crypto industry, ramping up regulatory crackdowns through initiatives like “Chokepoint 2.0.” Harris’s mislabelling of Ulbricht feels like just another example of the Democrats’ broader animosity toward crypto’s disruptive potential. Ross Ulbricht, the architect behind Silk Road For those less familiar with crypto lore, Ross Ulbricht is the architect behind Silk Road, the infamous online marketplace that used Bitcoin for transactions at a time when most people had never even heard of the cryptocurrency. Launched in 2011, Silk Road allowed users to buy and sell a range of goods (some legal, many not) outside the reach of traditional regulation. Ulbricht was arrested in 2013 and ultimately received a life sentence without the possibility of parole. It was a punishment many legal experts, tech leaders, and privacy advocates deemed excessive. His case became a flashpoint in debates about internet freedom, criminal justice reform, and the government’s approach to new technology. In January 2025, President Trump commuted Ulbricht’s sentence, allowing him to walk free after more…
Share
BitcoinEthereumNews2025/09/29 00:06